UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000032269 |
|---|---|
| Receipt number | R000036784 |
| Scientific Title | Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 4 With Combined Neurokinin-1 Receptor Antagonist, Palonosetron and Olanzapine in High- Emetogenic Chemotherapy |
| Date of disclosure of the study information | 2018/04/16 |
| Last modified on | 2022/04/19 17:47:09 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/04/16 19:15:20 | ||
| 2 | Update | 2018/09/30 09:38:47 | Public title |
|
| 3 | Update | 2018/09/30 09:40:58 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2019/04/21 12:17:05 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Organization Organization Category of Funding Organization Research ethics review Organization Organization Address Address Tel |
|
| 5 | Update | 2019/04/21 12:18:40 | Date of IRB Last follow-up date |
|
| 6 | Update | 2020/04/03 12:49:57 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator |
|
| 7 | Update | 2020/04/03 12:50:36 | Last follow-up date |
|
| 8 | Update | 2021/03/07 15:38:31 | Recruitment status |
|
| 9 | Update | 2021/04/18 15:37:32 | Number of participants that the trial has enrolled |
|
| 10 | Update | 2021/10/19 19:51:02 | Publication of results |
|
| 11 | Update | 2022/04/19 16:18:12 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 12 | Update | 2022/04/19 17:47:09 | Recruitment status |
